Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,450.00
Bid: 12,446.00
Ask: 12,450.00
Change: -16.00 (-0.13%)
Spread: 4.00 (0.032%)
Open: 12,466.00
High: 12,512.00
Low: 12,394.00
Prev. Close: 12,466.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Britain's FTSE recovers from Trump shock to hit one-week high

Wed, 09th Nov 2016 17:20

(ADVISORY- Follow European and UK stock markets in real time onthe Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets)

* FTSE 100 index closes 1 pct higher

* Miners, pharma stocks rally

* U.S.-exposed firms also gain

By Atul Prakash and Kit Rees

LONDON, Nov 9 (Reuters) - Britain's top share index endedhigher, boosted by mining companies and drugmakers, after avolatile Wednesday that saw the index slumping 2 percent inearly trading following Donald Trump's victory in the U.S.presidential election.

Republican Trump stunned the world by defeating his heavilyfavored Democratic rival, Hillary Clinton, raising concerns thathis victory could cause economic and global uncertainty. Stocksacross the globe initially fell, but then recovered followinghis well-received victory speech.

"Overall, a Trump victory has so far failed to trigger theglobal stock market panic that many expected. As with Brexit,this is a cautionary reminder not to try to base investmentstrategies on the outcome of political events," Laith Khalaf,senior analyst at Hargreaves Lansdown, said.

Credit Suisse analysts said that most of Trump's moretroubling policies, such as those related to immigration andprotectionism, were likely to be toned down. Some of his otherpolicies, like more fiscal spending and lower corporate taxes,could be seen as positive for equities.

Mining companies tracked a sharp rise in prices of gold,generally seen as a safe-haven asset, although it was off itshighs after the conciliatory victory speech that also helped thedollar to rebound. Base metals also rallied on expectations thata Trump presidency could herald a period of fiscal stimulus andboost demand for metals.

The UK mining index, which includes preciousand base metals companies, surged 5.9 percent to its highestsince mid-2015, boosted by a 6.8 to 10.7 percent jump inFresnillo, Antofagasta and Glencore.

The blue chip FTSE 100 index closed 1 percent higherafter setting a one-week high. The domestically focused FTSE 250index closed 0.8 percent higher.

Healthcare stocks spiked in a relief rally as Clinton wasseen as imposing tighter regulations. Pharma stocks had beenlosing ground before the election on worries that a Clintonpresidency would put pressure on drug prices.

Shares in Hikma, Shire, Astrazeneca and GlaxoSmithKline gained 2.7 to 8.3 percent.

Some companies with significant exposure to the UnitedStates also rose. CRH a construction firm which had beentouted as a potential beneficiary from any increase in U.S.infrastructure spending, jumped 6 percent, as it derives abouthalf of its revenues from the country.

U.S.-focused Ashtead soared 11.5 percent.

Shares in banking stocks rose 1.3 percent, inline with their European peers, with some analysts speculatingabout a more benign regulation in America and on expectationsthat the Fed could still raise interest rates this year.

However, some stocks came under heavy selling pressure.British grocer Sainsbury fell 6.6 percent afterreporting an underwhelming set of results. The supermarketreported a third straight decline in first-half profit, hurt bya fall in sales. (Reporting by Kit Rees; Editing by Larry King)

More News
3 Nov 2023 17:06

AstraZeneca plans next phase of trial on kidney drug combination data

(Alliance News) - AstraZeneca PLC on Friday touted results from a Phase IIb trial, which showed that a zibotentan and dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria.

Read more
3 Nov 2023 11:34

AstraZeneca's Lokelma lets kidney disease patients maintain therapy

(Alliance News) - AstraZeneca PLC on Thursday celebrated results from an observational study, which showed that treating hyperkalaemia with the potassium binder, Lokelma, allows chronic kidney disease and heart failure patients to maintain RAASi therapy.

Read more
2 Nov 2023 15:57

UK earnings, trading statements calendar - next 7 days

Friday 3 November 
no events scheduled 
Monday 6 November 
Kingspan Group PLCTrading Statement
Kosmos Energy LtdQ3 Results
Ryanair Holdings PLCHalf Year Results
Tuesday 7 November 
Associated British Foods PLCFull Year Results
Beazley PLCQ3 Results
Direct Line Insurance Group PLCTrading Statement
dotdigital Group PLCFull Year Results
IWG PLCQ3 Results
Persimmon PLCTrading Statement
RS Group PLCHalf Year Results
Vaalco Energy IncQ3 Results
Watches of Switzerland Group PLCTrading Statement
Wednesday 8 November 
Conduit Holdings LtdQ3 Results
ITV PLCTrading Statement
JD Wetherspoon PLCQ1 Results
Marks & Spencer Group PLCHalf Year Results
MaxCyte IncQ3 Results
Secure Trust Bank PLCTrading Statement
Smiths News PLCFull Year Results
Time Out Group PLCFull Year Results
Thursday 9 November 
3i Group PLCHalf Year Results
Apax Global Alpha LtdQ3 Results
AstraZeneca PLCQ3 Results
Auto Trader Group PLCHalf Year Results
B&M European Value Retail SAHalf Year Results
Domino's Pizza Group PLCTrading Statement
Endeavour Mining PLCQ3 Results
Flutter Entertainment PLCTrading Statement
IMI PLCTrading Statement
Indivior PLCQ3 Results
John Wood Group PLCTrading Statement
Lancashire Holdings LtdTrading Statement
National Grid PLCHalf Year Results
Regional REIT LtdTrading Statement
Renewi PLCHalf Year Results
S4 Capital PLCTrading Statement
Tate & Lyle PLCHalf Year Results
Taylor Wimpey PLCTrading Statement
TBC Bank Group PLCQ3 Results
TheWorks.co.uk PLCTrading Statement
Trakm8 Holdings PLCHalf Year Results
Urban Logistics REIT PLCHalf Year Results
Vistry Group PLCTrading Statement
WH Smith PLCFull Year Results
Wincanton PLCHalf Year Results
Wizz Air Holdings PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
1 Nov 2023 08:59

AstraZeneca launches collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Wednesday announced a new collaboration and investment agreement with clinical-stage biotechnology company Cellectis.

Read more
1 Nov 2023 07:33

AstraZeneca invests $220m in French gene-editing group Cellectis

(Sharecast News) - AstraZeneca is to invest in French biopharma group Cellectis to use its gene-editing technologies to develop next-gen therapeutics in areas like oncology, immunology and rare diseases.

Read more
30 Oct 2023 09:40

LONDON BROKER RATINGS: Jefferies cuts NatWest to underperform from buy

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
25 Oct 2023 11:04

PRESS: Soriot commits to five more years as AstraZeneca CEO - Times

(Alliance News) - Pascal Soriot has committed to remaining as chief executive officer of AstraZeneca PLC for another five years, The Times reported on Wednesday.

Read more
24 Oct 2023 17:08

LONDON MARKET CLOSE: FTSE 100 shakes off midday losses after US data

(Alliance News) - The FTSE 100 closed in the green on Tuesday following positive private sector data out of the US, despite figures closer to home showing a weaker UK private sector and rising unemployment.

Read more
24 Oct 2023 11:06

AstraZeneca says US accepts self-administered flu vaccine for review

(Alliance News) - AstraZeneca PLC on Tuesday said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine, for which the drugmaker is seeking a green light.

Read more
23 Oct 2023 17:50

AstraZeneca celebrates drug trial results for cancer indications

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer.

Read more
23 Oct 2023 17:08

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

Read more
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.